Abstract: There is provided a protease inhibitor and a method of inhibiting a protease selected from the group consisting of thrombin, chymotrypsin and neuropsin, by contacting the protease with an effective amount of a member of the phosphoethanolamine binding protein (PEBP) family.
Type:
Grant
Filed:
August 30, 2001
Date of Patent:
April 18, 2006
Assignee:
Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Instittue for Biomedical Research
Inventors:
Hugo Albrecht, Ulrich Hengst, Denis Monard